Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Cellectar Biosciences Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Cellectar Biosciences Inc. July 7, 202698.5%
-
Cellectar Biosciences Inc. June 23, 202395.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 17, 2026 | MaxCyte Inc. | Open-market sale | −10,142 | $0.82 | $8,316 |
| Aug 13, 2025 | MaxCyte Inc. | Open-market purchase | +50,000 | $1.29 | $64,500 |
| Mar 18, 2025 | MaxCyte Inc. | Open-market sale | −6,939 | $3.18 | $22,066 |
| Mar 14, 2025 | MaxCyte Inc. | Grant or award | +37,500 | — | — |
| Mar 15, 2024 | MaxCyte Inc. | Grant or award | +81,250 | — | — |
Questions about Douglas J. Swirsky
What boards is Douglas J. Swirsky on?
Douglas J. Swirsky sits on the board of Cellectar Biosciences Inc.
How long has Douglas J. Swirsky served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.